Prospective randomized evaluation of preoperative endoscopic vital staining using CH-40 for lymph node dissection in gastric cancer

Annals of Surgical Oncology

Volumn 5, Issue 7, 1998, Pages 580-584

  Catarci, Marco ^a   Guadagni, Stefano ^b   Zaraca, Francesco ^a   Pistoia, Maria Antonietta ^b   Mastracchio, Antonio ^a   Trecca, Antonello ^a   Ruco, Luigi ^a   Carboni, Manlio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

CH 40; Gastric cancer; Lymph nodes; Lymphadenectomy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; ENDOSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; RANDOMIZATION; STOMACH CANCER; VITAL STAIN;

EID: 0031755095     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02303825     Document Type: Article

References (28)

1. Hagiwara A, Ahn T, Ueda T, et al. Anticancer agents adsorbed by activated carbon particles, a new form of dosage enhancing efficacy on lymph nodal metastases. Anticancer Res 1986;8:287-90.
2. Hagiwara A, Takahashi T, Lee R, Ueda T, Takeda M, Itoh T. Chemotherapy for carcinomatous peritonitis and pleuritis with MMC-CH, mitomycin C adsorbed on activated carbon particles: clinical trials. Cancer 1987;59:245-51.
3. Takahashi T, Sawai K, Hagiwara A, Takahashi S, Seiki K, Tokuda H. Type-oriented therapy for gastric cancer effective for lymph node metastasis: management of lymph node metastasis using activated carbon particles adsorbing an anticancer agent. Semin Surg Oncol 1991;7:378-83.
4. Hagiwara A, Takahashi T, Kojima O, et al. Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer. Lancet 1992;339:629-31.
5. Kitamura K, Hagiwara A, Otsuji E, et al. Activated carbon-oriented gastrectomy for early gastric cancer. Br J Surg 1995;82:647-9.
6. Maruyama K. Surgical Treatment and End Results of Gastric Cancer. Tokyo: National Cancer Center Press, 1986.
7. Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987;11:418-25.
8. Maruyama K, Kinoshita T, Sasako M, Okabayashi K. New technologies in gastric cancer surgery: computer system to make operation plan and intraoperative staining of regional lymph nodes for complete dissection. In: Reed PI, Carboni M, Johnston B, Guadagni S, eds. New Trends in Gastric Cancer. London: Kluwer Academic Publishers, 1990:107-18.
9. Bonenkamp JJ, Songun I, Hermans J, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995;345:745-8.
10. Cuschieri A. Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet 1996:347:995-9.
11. Guadagni S, Catarci M, de Manzoni G, Kinoshita T. D1 versus D2 dissection for gastric cancer (letter). Lancet 1995;345:1517.
12. Sano T, Martin IG. Lymphadenectomy and pancreaticosplenectomy in gastric cancer surgery (letter). Lancet 1996;348:195-6.
13. Parikh D, Johnson M, Chagla L, Lowe D, McCulloch P. D2 gastrectomy: lessons from a prospective audit of the learning curve. Br J Surg 1996;83:1595-9.
14. Smith JW, Shiu MH, Kelsey L, Brennan MF. Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma. Arch Surg 1991;126:1469-73.
15. Siewert JR, Böttcher K, Roder JD, Busch R, Hermanek P, Meyer HJ. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg 1993:80:1015-18.
16. Pacelli F, Doglietto GB, Bellantone R, Alfieri S, Sgadari A, Crucitti F. Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients. Br J Surg 1993;80:1153-6.
17. Sue-Ling HM, Johnston B, Martin IG, et al. Gastric cancer: a curable disease in Britain. Br Med J 1993;307:591-6.
18. de Manzoni G, Verlato G, Guglielmi A, Laterza E, Genna M, Cordiano C. Prognostic significance of lymph node dissection in gastric cancer. Br J Surg 1996;83:1604-7.
19. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma. 1st English ed. Tokyo: Kanehara, 1995.
20. Hagiwara A, Takahashi T, Sawai K, et al. Lymph nodal vital staining with newer carbon particle suspensions compared with india ink: experimental and clinical observations. Lymphology 1992;25:84-9.
21. Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H, Okajima K. Pancreas-preserving total gastrectomy for proximal gastric cancer. World J Surg 1995;19:532-6.
22. Lauren P. The two histologic main type of gastric carcinoma: diffuse and so-called intestinal type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
23. UICC. TNM Classification of Malignant Tumors. 4th ed. Berlin: Springer Verlag, 1987.
24. Bunt AMG, Hermans J, Boon MC, et al. Evaluation of the extent of lymphadenectomy in a randomized trial of western- versus Japanese-type surgery in gastric cancer. J Clin Oncol 1994;12:417-22.
25. Sasako M, McCulloch P, Kinoshita T, Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 1995;346-51.
26. Gunvén P, Maruyama K, Okabayashi K, Sasako M, Kinoshita T. Non-ominous micrometastases of gastric cancer. Br J Surg 1991;78:352-4.
27. Baba H, Machara Y, Takeuchi H, et al. Effect of lymph node dissection on the prognosis in patients with node-negative early gastric cancer. Surgery 1994;117:165-9.
28. Siewert JR, Kestlmeier R, Busch R, et al. Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg 1996;83:1144-7.